glp-1 semaglutide for Weight Loss: How It Works and What to Expect Troubling Findings in Study of

In the United States alone, the number of patients starting GLP-1 treatments for non-diabetic purposes has increased by 700% since 2019, with estimates suggesting that over 220,000 patients started treatment each month in 2024

The I VIT 12 COMBINATION PACK INJECTION 2.5ML combines four active ingredients each of which has a unique role: Ascorbic Acid (150 mg): Known as Vitamin C, it is essential for collagen synthesis, tyrosine metabolism, and immune function

S2CID 24024090

However, increasing competition, generic liraglutide availability, upcoming semaglutide patent expiration (2026), and Novo Nordisks announced list price cuts are all expected to improve affordability over the coming years